Articles and Blogs

This past week, the Drug Enforcement Administration (“DEA”) and the U.S. Department of Health and Human Services (“HHS,” and together with the DEA, the “Agencies”) announced the release of three highly anticipated rules related to the prescription of controlled substances through telemedicine. These new rules include: A final rule on the “Expansion of Buprenorphine Treatment... READ MORE